Representing pharmaceutical, medical device, diagnostic, and medical supply companies in healthcare fraud investigations conducted by federal and state enforcement agencies involving billing and pricing issues, allegations of improper sales and marketing practices, allegations of off-label promotion, and alleged violations of the False Claims Act and the Anti-Kickback Statute.
Representing major airline in ongoing federal criminal and civil investigations in connection with federal contract issues.
Representing diabetes test supply company in intervened False Claims Act case pending in Tennessee regarding alleged violations of the Anti-Kickback Statute.
Representing pharmaceutical manufacturer in False Claims Act pending in Illinois regarding alleged violations of the Anti-Kickback Statute in connection with product support program.
Represented medical device manufacture in False Claims Act case in Texas regarding the alleged off-label promotion of a medical device. Following three week trial in which over $1 billion in damages was sought, the jury returned a complete defense verdict after three hours of deliberation.
Represented diabetes test supply company in False Claims Act case pending in Florida regarding various alleged regulatory violations and violations of the Anti-Kickback Statute. Case dismissed.
Represented pharmaceutical company in case brought by the California Department of Insurance alleging violations of the California Insurance Frauds Prevention Act regarding alleged improper kickbacks in connection with product support program and other alleged conduct. Case settled favorably.
Represented pharmaceutical company in False Claims Act case pending in Texas regarding alleged violations of the Anti-Kickback Statute in connection with product support program. Case dismissed.
Represented pharmaceutical company in False Claims Act case pending in New Jersey regarding alleged violations of the Anti-Kickback Statute in connection with product support program. Case dismissed.
Represented medical device company in False Claims Act case pending in Texas regarding alleged violations of the Anti-Kickback Statute in connection with product support program. Case dismissed.
Represented diagnostics company in False Claims Act case pending in Massachusetts regarding alleged improper billing practices. Case dismissed.
Represented diagnostics company in qui tam litigation under the California Insurance Frauds Prevention Act regarding alleged improper billing practices. Case dismissed on summary judgment.
Represented pharmaceutical company in False Claims Act case pending in Pennsylvania regarding the alleged off-label promotion of a prescription drug and other alleged improper sales and marketing practices. Case settled favorably.
Represented medical device manufacturer in False Claims Act case pending in Massachusetts regarding the alleged improper off-label promotion of medical devices and other alleged improper sales and marketing practices. False Claims Act claims dismissed with prejudice and retaliation claims dismissed on summary judgment.
Represented pharmaceutical company in False Claims Act case pending in Ohio regarding the alleged off-label and improper promotion of several prescription drugs and other alleged improper sales and marketing practices. Case dismissed.
Represented pharmaceutical manufacturers in various actions brought in state and federal courts on behalf of state Medicaid agencies and the federal government asserting that prescription pharmaceutical manufacturers reported inaccurate pricing benchmarks, allegedly causing the states and federal government to overpay providers for drugs dispensed to Medicaid and Medicare beneficiaries. Cases settled favorably.